MA22196A1 - Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes - Google Patents

Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes

Info

Publication number
MA22196A1
MA22196A1 MA22442A MA22442A MA22196A1 MA 22196 A1 MA22196 A1 MA 22196A1 MA 22442 A MA22442 A MA 22442A MA 22442 A MA22442 A MA 22442A MA 22196 A1 MA22196 A1 MA 22196A1
Authority
MA
Morocco
Prior art keywords
leucotrienes
preparation
treatment
benzoic acid
acid derivatives
Prior art date
Application number
MA22442A
Other languages
English (en)
Inventor
A Daines Robert
Nmi Pendrak I
D Kingsbury William
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA22196A1 publication Critical patent/MA22196A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA22442A 1990-06-07 1991-06-03 Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes MA22196A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53438890A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
MA22196A1 true MA22196A1 (fr) 1992-04-01

Family

ID=24129833

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22442A MA22196A1 (fr) 1990-06-07 1991-06-03 Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes

Country Status (16)

Country Link
EP (1) EP0532550A1 (fr)
JP (1) JPH05507475A (fr)
KR (1) KR930700445A (fr)
CN (1) CN1058016A (fr)
AU (1) AU7901791A (fr)
CA (1) CA2083958A1 (fr)
FI (1) FI925544A (fr)
HU (1) HUT64748A (fr)
IE (2) IE911913A1 (fr)
IL (1) IL98388A0 (fr)
MA (1) MA22196A1 (fr)
MX (1) MX26142A (fr)
PL (1) PL290586A1 (fr)
PT (1) PT97912A (fr)
WO (1) WO1991018880A1 (fr)
ZA (1) ZA914323B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4226493A (en) * 1992-05-01 1993-11-29 Smithkline Beecham Corporation Leukotriene antagonists
WO1995015950A1 (fr) * 1993-12-08 1995-06-15 Smithkline Beecham Corporation Composes
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds
WO1994014442A1 (fr) * 1992-12-23 1994-07-07 Smithkline Beecham Corporation Composes de pyridyle a substitution utiles comme antagonistes des leucotrienes
BR9507459A (pt) * 1994-04-13 1997-11-11 Hoffmann La Roche Antagonistas á base de piridino-leucotrieno b4 substituído
US7297357B2 (en) * 2001-03-27 2007-11-20 Meiji Seika Kaisha, Ltd. Process for producing puffed snack and production apparatus therefor
ES2622522T3 (es) 2003-08-26 2017-07-06 The Regents Of The University Of Colorado, A Body Corporate Inhibidores de la actividad proteasa de serina y su uso en métodos y composiciones para el tratamiento de infecciones bacterianas
US8093253B2 (en) 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563446A (en) * 1983-07-27 1986-01-07 Takeda Chemical Industries, Ltd. Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
EP0532550A1 (fr) 1993-03-24
FI925544A0 (fi) 1992-12-07
HUT64748A (en) 1994-02-28
CA2083958A1 (fr) 1991-12-08
JPH05507475A (ja) 1993-10-28
AU7901791A (en) 1991-12-31
ZA914323B (en) 1992-06-24
IE911912A1 (en) 1991-12-18
IE911913A1 (en) 1991-12-18
HU9203866D0 (en) 1993-03-29
FI925544A (fi) 1992-12-07
MX26142A (es) 1994-02-28
WO1991018880A1 (fr) 1991-12-12
CN1058016A (zh) 1992-01-22
IL98388A0 (en) 1992-07-15
PT97912A (pt) 1992-03-31
PL290586A1 (en) 1992-04-06
KR930700445A (ko) 1993-03-15

Similar Documents

Publication Publication Date Title
RO76614A (fr) Procede pour la preparation des derives de 3,4-dehydroproline et d'acide 4,5-dehydropipecolique
MA21922A1 (fr) Procede de purification d'acides aminomethylene-phosphoniques .
MA22195A1 (fr) Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux lencotrienes
MC1998A1 (fr) Composes pour le traitement des maladies hyperproliferatibes et procede de preparation
MA22196A1 (fr) Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes
MA22649A1 (fr) Procede de preparation de composes pour le traitement des maladies en rapport avec le leucotriene .
MA22197A1 (fr) Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes
MA19444A1 (fr) Procede de preparation de nouveaux derives d'acide phenylaliphatique carboxyliques
FR2602229B1 (fr) Procede de preparation d'esters d'acides carboxyliques insatures
RO80004A (fr) Procede pour la preparation des derives de l'ester de l'acide cyclopropancarboxylique
FR2666808B1 (fr) Procede de preparation de l'acide adipique par hydrocarboxylation d'acides penteniques.
PT74766B (fr) Procede de preparation de nouveaux derives de l'acide cyclopropane carboxylique
RO83707A (fr) Procede pour la preparation des esters chlormethyliques des derives de l'acide penycilanique
FR2626884B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique et de chlorure d'acide en resultant
FR2677354B1 (fr) Procede pour la preparation d'esters d'acides racemisables.
RO84278A (fr) Procede pour la preparation des derives de l'acide penycilanique
FR2726557B1 (fr) Procede de preparation d'acides carboxyliques par carbonylation en presence de rhodium
PT69151A (fr) Procede de preparation de derives d'acide naphtyl-1 acetique
FR2669330B1 (fr) Procede de preparation de l'acide betha-mercaptopropionique.
FR2656528B1 (fr) Formule combinee de cimetidine-pirenzepine pour le traitement des ulceres simples de l'estomac et des erosions et procede de traitement.
FR2663024B1 (fr) Procede de preparation d'acide (2-hydroxyphenyl) acetique.
RO81937A (fr) Procede pour la preparation des derives de l'acide 7 beta-aminothiazolylacetamido-3-cephem-4-carboxylique
FR2724378B1 (fr) Procede de preparation de l'acide picrique
FI96689B (fi) Menetelmä terapeuttisesti käyttökelpoisten -oksopyrrolo/2,3-b/indolietikkahappoestereiden ja -amidien valmistamiseksi
FR2542758B1 (fr) Procede de preparation de l'acide l-glutamique